Trypanosoma cruzi metacyclic trypomastigotes (MT), but not blood form trypomastigotes (BFT), are highly mucosally infective. We investigated the abilities of MT and BFT to induce inflammation and/or intracellular killing activity within mucosal epithelia. BFT, but not MT, induced marked increases in interleukin-8, GRO-␣, MCP-1, and nitric oxide production in HeLa and AGS cells, despite similar infectivities. MT may avoid induction of inflammation as an important biological mechanism facilitating mucosal invasion.An estimated 16 to 18 million people in South and Central America are infected with Trypanosoma cruzi, the protozoan parasite causing Chagas' disease (7). Fifty thousand deaths per year result from the cardiac and gastrointestinal pathology due to chronic T. cruzi infection. T. cruzi is most commonly transmitted to humans through contact with the infected feces of the reduviid bug. T. cruzi metacyclic trypomastigotes (MT) in reduviid bug feces can initiate infection through cuts in the skin or through contact with mucosal surfaces, including the eyes and mouth. T. cruzi MT infect epithelial cells, develop, and replicate intracellularly as amastigotes and are released from lysed host cells as blood form trypomastigotes (BFT). BFT are then able to infect new epithelial cells and most other types of mammalian host cells and repeat the intracellular replication cycle. T. cruzi MT are able to initiate infection through the conjunctival and gastrointestinal mucosa. On the other hand, we have shown that BFT are unable to infect through mucosal surfaces (14). The mechanisms responsible for the mucosal invasiveness of MT, but not BFT, are not known.Tissue infection with T. cruzi elicits significant inflammation responsible for the pathology associated with Chagas' disease. BFT, but not MT, infection of macrophages induces proinflammatory cytokine and nitric oxide (NO) production (8). The effects of T. cruzi infection on proinflammatory responses in epithelial cells, however, have not been reported. We found that mice challenged orally with MT do not develop detectable mucosal inflammation until 4 to 7 days after infection, sufficient time for three to four cycles of replication and 100-to 1,000-fold amplification of BFT (16). We hypothesize that the inability of MT to induce inflammatory mediators could be important for T. cruzi mucosal infectivity. On the other hand, it may be advantageous for later stages of infection with BFT to induce inflammation, prolonging the life of the host by preventing uncontrolled parasite replication.We studied the ability of T. cruzi strain Tulahuén MT and BFT to induce chemokine responses in mucosal epithelial cells. Culture-derived MT were prepared by subculture of axenically cultivated epimastigotes into modified Grace's medium (Sigma, St. Louis, Mo.) for 7 to 10 days. These culturederived MT are morphologically similar to insect-derived MT and are mucosally infective (20). Insect-derived MT were prepared by allowing T. cruzi-infected reduviid bugs (Dipetalogaster maximus) to fe...